1.56
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eloxx Pharmaceuticals Inc | ELOX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.56 | 1.44 | 1.5879 | 1.58 | 1.56 | 19:34:20 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.44 | 1.75 | 0.31 | 17.71% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 629 | 69,110 | $ 1.54 | $ 106,115 | 126,552 | 1.44 - 13.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:04 | 1 | $ 1.56 | USD |
Eloxx Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 62.60M | 40.13M | $ -47.19M | -1.34 | - | 20.55M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 19.00 | 48.80% |
Eloxx Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELOX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.28 | 2.74 | 1.44 | 1.83 | 90,820 | -0.72 | -31.58% |
| 1 Month | 3.54 | 3.83 | 1.44 | 2.53 | 131,297 | -1.98 | -55.93% |
| 3 Months | 7.60 | 7.93 | 1.44 | 3.83 | 157,226 | -6.04 | -79.47% |
| 6 Months | 4.05 | 8.1614 | 1.44 | 5.31 | 219,367 | -2.49 | -61.48% |
| 1 Year | 11.66 | 13.46 | 1.44 | 5.98 | 147,468 | -10.10 | -86.62% |
| 3 Years | 10.35 | 24.60 | 1.44 | 9.54 | 120,180 | -8.79 | -84.93% |
| 5 Years | 10.35 | 24.60 | 1.44 | 9.54 | 120,180 | -8.79 | -84.93% |
Eloxx Pharmaceuticals Description
| Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. |
